Adopted opinions and previous consultations on applications for authorisation

This page provides further information on the applications for authorisation or review reports, which have undergone consultation. The applications for authorisation are in the opinion development phase until the final opinions of the Committees for Risk Assessment and Socio-economic Analysis have been adopted and sent to the European Commission. Its decision-making process can be followed through the comitology register, where further information is published about the REACH Committee's past and upcoming meetings.

On 1 February 2020, the United Kingdom (UK) withdrew from the EU. The transition period provided by the withdrawal agreement ended on 31 December 2020. As of 1 January 2021, an application for an authorisation submitted by a person established in the UK (except Northern Ireland) is no longer valid in the EU, unless that application has been transferred to a legal entity established in the EU or Northern Ireland before the end of the transition period. Therefore, authorisation applications and decisions in so far as these concern persons established in the UK (except Northern Ireland) are no longer considered valid.

ID	Application type	Name	EC Number	CAS Number	Applicant(s)	Use name	Status
0352-01	Initial	Bis(2-ethylhexyl) phthalate	204-211-0	117-81-7	Baxter SA; Baxter Healthcare SA; Gambro Dasco SpA; Baxter (Malta) Trading Co Ltd; Colorite Europe Ltd.	Formulation of DEHP mixtures for application in immediate packaging of medicines and medical devices	Opinion development	Details
0352-02	Initial	Bis(2-ethylhexyl) phthalate	204-211-0	117-81-7	Baxter SA; Baxter Healthcare SA; Gambro Dasco SpA; Baxter (Malta) Trading Co Ltd	Use of DEHP-containing plastics for immediate packaging of medicinal products	Opinion development	Details
0352-03	Initial	Bis(2-ethylhexyl) phthalate	204-211-0	117-81-7	Baxter SA; Baxter Healthcare SA; Gambro Dasco SpA; Baxter (Malta) Trading Co Ltd	Use of DEHP-based mixtures as a lubricating/sealing agent for the insertion of port closures into empty bags and assembly/connection of parts, that are used in immediate packaging of medicines	Opinion development	Details
0353-01	Initial	Tetraethyllead	201-075-4	78-00-2	Shell Nederland Raffinaderij B.V.	Use of tetraethyl lead in the formulation of aviation fuel	Opinion development	Details
0354-01	Review report	Chromium trioxide	215-607-8	1333-82-0	Airbus Helicopters Technik GmbH	Use as a surface hardener (functional chrome plating) in the manufacture of helicopter transmissions and the maintenance of helicopters.	Opinion development	Details
0354-02	Review report	Chromium trioxide	215-607-8	1333-82-0	Airbus Helicopters Technik GmbH	Surface treatment (as corrosion inhibitor, no connection with functional chrome plating) in the manufacture of helicopter transmissions and the maintenance of helicopters.	Opinion development	Details
0355-01	Review report	Sodium dichromate	234-190-3	10588-01-9	Airbus Helicopters Technik GmbH	Surface treatment of metals (such as aluminium, steel, zinc, magnesium, titanium, alloys), composites and sealings of anodic films, in the production of transmissions for helicopters and in maintenance of helicopters.	Opinions adopted	Details
0356-01	Review report	Sodium dichromate	234-190-3	10588-01-9	AD International BV	Use of SDC in formulation of mixtures intended for supply for authorised uses	Opinion development	Details
0357-01	Review report	potassium dichromate	231-906-6	7778-50-9	LYNRED	Industrial use of potassium dichromate-based mixtures during the step of final etching of CZT layers during the production of opto-electronic components gathering a readout and an infrared detecting circuit with the MCT technology.	Opinion development	Details
0358-01	Review report	Arsenic acid	231-901-9	7778-39-4	CIRCUIT FOIL LUXEMBOURG SARL	Industrial use of arsenic acid for the treatment of copper foil used in the manufacture of printed circuit board.	Opinion development	Details

Showing 551 - 560 of 567 results.

Export in: